These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1703987)

  • 1. Antigen presentation and HLA-DR expression by FK-506-treated human monocytes.
    Woo J; Propper DJ; Thomson AW
    Immunology; 1990 Dec; 71(4):551-5. PubMed ID: 1703987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of FK-506 and low-concentration ciclosporin on human lymphocyte activation antigen expression and blastogenesis: a flow cytometric analysis.
    Woo J; Sewell HF; Thomson AW
    Scand J Immunol; 1990 Mar; 31(3):297-304. PubMed ID: 1690915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human monocyte antigen presentation, but not HLA-DR expression, by cyclosporine.
    Snyder DS; Wright CL; Ting C
    Transplantation; 1987 Sep; 44(3):407-11. PubMed ID: 3114926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.
    Dumont FJ; Staruch MJ; Koprak SL; Melino MR; Sigal NH
    J Immunol; 1990 Jan; 144(1):251-8. PubMed ID: 1688572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional abolition of monocyte HLA-DR by aldehyde treatment. A novel approach to studies of class II restriction elements in antigen presentation.
    Rhodes J; Tite J
    J Immunol; 1988 May; 140(10):3344-51. PubMed ID: 3361123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation.
    Bierer BE; Schreiber SL; Burakoff SJ
    Eur J Immunol; 1991 Feb; 21(2):439-45. PubMed ID: 1705513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.
    Dumont FJ; Melino MR; Staruch MJ; Koprak SL; Fischer PA; Sigal NH
    J Immunol; 1990 Feb; 144(4):1418-24. PubMed ID: 1689353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes.
    Lin CS; Boltz RC; Siekierka JJ; Sigal NH
    Cell Immunol; 1991 Apr; 133(2):269-84. PubMed ID: 1707760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of FK 506 and low concentration cyclosporine on human lymphocyte activation antigen expression: a flow cytometric analysis.
    Woo J; Sewell HF; Thomson AW
    Transplant Proc; 1990 Aug; 22(4):1645-6. PubMed ID: 1697113
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence that cyclosporine inhibits cell-mediated immunity primarily at the level of the T lymphocyte rather than the accessory cell.
    Granelli-Piperno A; Keane M; Steinman RM
    Transplantation; 1988 Aug; 46(2 Suppl):53S-60S. PubMed ID: 3136567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506.
    Kay JE; Benzie CR; Goodier MR; Wick CJ; Doe SE
    Immunology; 1989 Aug; 67(4):473-7. PubMed ID: 2475433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4 decreases the expression of the monocyte differentiation marker CD14, paralleled by an increasing accessory potency.
    Ruppert J; Friedrichs D; Xu H; Peters JH
    Immunobiology; 1991 Aug; 182(5):449-64. PubMed ID: 1717365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrocortisone-mediated inhibition of monocyte antigen presentation: dissociation of inhibitory effect and expression of DR antigens.
    Gerrard TL; Cupps TR; Jurgensen CH; Fauci AS
    Cell Immunol; 1984 May; 85(2):330-9. PubMed ID: 6608999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressant deoxyspergualin inhibits antigen processing in monocytes.
    Hoeger PH; Tepper MA; Faith A; Higgins JA; Lamb JR; Geha RS
    J Immunol; 1994 Nov; 153(9):3908-16. PubMed ID: 7930603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of FK-506 and cyclosporine on human T and B lymphoproliferative responses.
    Wasik M; Stepień-Sopniewska B; Lagodziński Z; Górski A
    Immunopharmacology; 1990; 20(1):57-61. PubMed ID: 1699911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of antigen-induced T cell proliferation by alpha 2M-trypsin complexes.
    Mannhalter JW; Borth W; Eibl MM
    J Immunol; 1986 Apr; 136(8):2792-9. PubMed ID: 2420868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-presenting capacity of alveolar macrophages and monocytes in pulmonary tuberculosis.
    Ina Y; Takada K; Yamamoto M; Morishita M; Yoshikawa K
    Eur Respir J; 1991 Jan; 4(1):88-93. PubMed ID: 2026242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of interleukin 1 receptors on human peripheral T cells.
    Shirakawa F; Tanaka Y; Ota T; Suzuki H; Eto S; Yamashita U
    J Immunol; 1987 Jun; 138(12):4243-8. PubMed ID: 2953802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.
    Le JM; Vilcek J
    J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of T and B lymphocyte proliferation by rapamycin.
    Kay JE; Kromwel L; Doe SE; Denyer M
    Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.